Sidero Biosciences, LLC (Sidero) is a clinical stage biotechnology company advancing disruptive technologies targeting human digestive health. Our technologies utilize the SideroSorb platform, which delivers beneficial proteins/complexes directly to the gastrointestinal (GI) tract to ameliorate human disease.
Our latest innovation, BioFe, is an oral iron supplement that targets iron deficiencies through a new uptake mechanism. This mechanism mimics the body's natural pathway of transporting iron through the umbilical cord and breast feeding, avoiding GI distress other iron supplements tend to produce.
Sidero is poised to rapidly advance a market launch with BioFe, our lead product.